Abnormally high methylation levels of FAM135B have been identified as a positive independent prognostic biomarker of OS in HNSCC patients [25], whereas a prognostic signature of four methylated genes has been associated with prognosis and survival in patients with HNSCC who either did or did not receive radiotherapy [41]. Here, FAM135B is linked to head and neck squamous cell carcinoma.